Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways

Cisplatin is a widely used anti-cancer drug. The B-cell translocation gene 2 (BTG2) is involved in the cell cycle transition regulation. We evaluated the cisplatin effects on prostate cancer cell proliferation and the expressions of BTG2, p53, androgen receptor (AR) and prostate specific antigen (PS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Kun-Chun, Tsui, Ke-Hung, Chung, Li-Chuan, Yeh, Chun-Nan, Feng, Tsui-Hsia, Chen, Wen-Tsung, Chang, Phei-Lang, Chiang, Hou-Yu, Juang, Horng-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076686/
https://www.ncbi.nlm.nih.gov/pubmed/24981574
http://dx.doi.org/10.1038/srep05511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076686/
https://www.ncbi.nlm.nih.gov/pubmed/24981574
http://dx.doi.org/10.1038/srep05511

Ejemplares similares